- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
BIOFIL Chemicals and Pharmaceuticals Limited has confirmed that all securities received for dematerialization during the quarter ended 31 December 2024 were appropriately processed by their Registrar and Share Transfer Agent, Ankit Consultancy Pvt Ltd. The securities have been successfully listed on the relevant stock exchanges, and any physical security certificates for dematerialization have been mutilated and canceled after verification.
This update assures shareholders of proper compliance and management of their securities, potentially enhancing investor confidence. The efficient handling of dematerialization can signal operational strength, fostering a positive outlook among investors.
All announcements from Biofil Chemicals & Pharmaceuticals Limited